Glenmark starts manufacturing samples at new plant in Indore

02 Feb 2011 Evaluate

Glenmark Pharmaceuticals has started manufacturing samples at its new plant in Indore. These samples will be shipped for the approval of the US Food and Drug Authority (USFDA) before it can launch the products at the world’s largest drug market. The company has invested 80-100 crore in the plant that has initial capacity to manufacture a million tablets per year solely for exports to US and the UK. Glenmark is hoping to get USFDA approval for the plant within a year, which will be crucial for its revenue growth from 2012 as the firm estimates it will run out of capacity in its existing manufacturing units within a year or so.crackcrack

Glenmark Pharma Share Price

1178.00 17.25 (1.49%)
03-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1453.25
Dr. Reddys Lab 5792.95
Cipla 1459.85
Zydus Lifesciences 1032.25
Lupin 1583.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.